Ophthalmology · Endocrine Complications
The facts most likely to be tested
Non-proliferative diabetic retinopathy is characterized by microaneurysms, dot-and-blot hemorrhages, and hard exudates on funduscopic examination.
Proliferative diabetic retinopathy is defined by the presence of neovascularization due to retinal ischemia and VEGF release.
Cotton-wool spots represent nerve fiber layer infarctions and are a hallmark finding of pre-proliferative diabetic retinopathy.
Diabetic macular edema is the most common cause of vision loss in patients with diabetic retinopathy and is best visualized via optical coherence tomography (OCT).
Panretinal photocoagulation (PRP) is the gold-standard treatment for proliferative diabetic retinopathy to induce regression of neovascularization.
Intravitreal anti-VEGF injections (e.g., ranibizumab, aflibercept) are the first-line therapy for diabetic macular edema.
Tight glycemic control and blood pressure management are the most effective strategies to slow the progression of diabetic retinopathy.
Vignette unlocked
A 58-year-old male with a 15-year history of type 2 diabetes mellitus presents for a routine follow-up. He reports no acute vision changes, but funduscopic examination reveals scattered microaneurysms, dot-and-blot hemorrhages, and yellow-white hard exudates in the posterior pole. There is no evidence of neovascularization or vitreous hemorrhage. His HbA1c is 8.2%.
What is the most appropriate next step in the management of this patient's ocular findings?
Strict glycemic control and annual dilated eye examinations
The patient presents with non-proliferative diabetic retinopathy; the primary management strategy is to optimize systemic risk factors (glucose and blood pressure) to prevent progression to the proliferative stage.
Full handout
High yield triage
Etiology / Epidemiology
Leading cause of new-onset blindness in adults; duration of diabetes and poor glycemic control are primary drivers.
Clinical Manifestations
Presents with cotton wool spots, microaneurysms, and neovascularization; patients often report blurred vision or floaters.
Diagnosis
Gold standard is dilated funduscopic exam; annual screening is mandatory for all patients with Type 2 DM.
Treatment
First-line is panretinal laser photocoagulation for proliferative disease; avoid rapid glucose correction to prevent worsening.
Prognosis
Risk of macular edema is the most common cause of vision loss; requires annual ophthalmology follow-up.
Full handout
Epidemiology & Etiology
Prevalence correlates directly with duration of disease and HbA1c levels. Hypertension and hyperlipidemia act as synergistic risk factors for progression. It remains the most common cause of irreversible blindness in working-age adults.
Pertinent Anatomy
The macula is responsible for central vision and is the primary site of vision-threatening edema. The retina contains microvasculature highly susceptible to chronic hyperglycemia-induced damage.
Pathophysiology
Chronic hyperglycemia leads to pericyte loss and basement membrane thickening, causing capillary leakage and ischemia. Ischemia triggers the release of vascular endothelial growth factor (VEGF), promoting abnormal neovascularization. These fragile vessels are prone to rupture, leading to vitreous hemorrhage and retinal detachment.
Clinical Manifestations
Non-proliferative stages show microaneurysms, dot-and-blot hemorrhages, and cotton wool spots. Proliferative disease is defined by neovascularization and fibrous proliferation. Sudden vision loss suggests vitreous hemorrhage or retinal detachment, which are medical emergencies.
Diagnosis
The dilated funduscopic exam is the gold standard for staging. Optical coherence tomography (OCT) is used to quantify macular edema. Annual screening is required for all diabetics to detect asymptomatic progression.
Treatment
Management focuses on glycemic control and blood pressure optimization. Panretinal laser photocoagulation is the standard for proliferative retinopathy. Intravitreal anti-VEGF injections (e.g., ranibizumab) are first-line for diabetic macular edema. Avoid rapid glycemic lowering as it can paradoxically worsen retinopathy.
Prognosis
Vision loss is primarily due to diabetic macular edema or complications of neovascularization. Patients require annual ophthalmology exams; high-risk patients require more frequent monitoring to prevent permanent visual impairment.
Differential Diagnosis
Hypertensive Retinopathy: presence of copper wiring and AV nicking
Retinal Vein Occlusion: sudden painless vision loss with blood and thunder fundus
Retinal Artery Occlusion: cherry-red spot on fovea with sudden monocular blindness
Age-related Macular Degeneration: drusen deposits and central scotoma
Retinal Detachment: curtain coming down over visual field